A Phase I Trial of CT900, a Novel α-Folate Receptor–Mediated Thymidylate Synthase Inhibitor, in Patients with Solid Tumors with Expansion Cohorts in Patients with High-Grade Serous Ovarian Cancer

JOURNAL ARTICLE published 1 November 2022 in Clinical Cancer Research

Authors: Susana Banerjee | Vasiliki Michalarea | Joo Ern Ang | Alvaro Ingles Garces | Andrea Biondo | Ionut-Gabriel Funingana | Martin Little | Ruth Ruddle | Florence Raynaud | Ruth Riisnaes | Bora Gurel | Sue Chua | Nina Tunariu | Joanna C. Porter | Toby Prout | Mona Parmar | Anna Zachariou | Alison Turner | Ben Jenkins | Stuart McIntosh | Ed Ainscow | Anna Minchom | Juanita Lopez | Johann de Bono | Robert Jones | Emma Hall | Natalie Cook | Bristi Basu | Udai Banerji

Monitoring Drug-Induced γH2AX as a Pharmacodynamic Biomarker in Individual Circulating Tumor Cells

JOURNAL ARTICLE published 1 February 2010 in Clinical Cancer Research

Authors: Lihua H. Wang | Thomas D. Pfister | Ralph E. Parchment | Shivaani Kummar | Larry Rubinstein | Yvonne A. Evrard | Martin E. Gutierrez | Anthony J. Murgo | Joseph E. Tomaszewski | James H. Doroshow | Robert J. Kinders

Abstract 10: Concordance of BAP1, PBRM1, Ki-67, and TOPOIIa protein expression in primary clear cell renal cell carcinoma tumors and patient-matched metastatic tumors

JOURNAL ARTICLE published 1 January 2016 in Clinical Cancer Research

Authors: Jeanette E. Eckel-Passow | Daniel J. Serie | John C. Cheville | Thai H. Ho | Sue M. Harrington | Tracy Hilton | Christine Lohse | Amanda Shreders | Payal Kapur | James Brugarolas | R Houston Thompson | Bradley C. Leibovich | Eugene D. Kwon | Richard W. Joseph | Alexander S. Parker

A Prognostic Model Based on Residual Cancer Burden and Tumor-Infiltrating Lymphocytes on Residual Disease after Neoadjuvant Therapy in HER2+ Breast Cancer

JOURNAL ARTICLE published 1 September 2023 in Clinical Cancer Research

Research funded by Fondazione AIRC 5 per mille (22759) | University of Padua (DOR funding) | University of Padua (DOR funding) | University of Padua (DOR funding)

Authors: Federica Miglietta | Moira Ragazzi | Bethania Fernandes | Gaia Griguolo | Davide Massa | Fabio Girardi | Michele Bottosso | Alessandra Bisagni | Giovanni Zarrilli | Francesca Porra | Daniela Iannaccone | Leocadia Dore | Mariangela Gaudio | Giacomo Santandrea | Matteo Fassan | Marcello Lo Mele | Rita De Sanctis | Alberto Zambelli | Giancarlo Bisagni | Valentina Guarneri | Maria Vittoria Dieci

Phase I Clinical Trial of the Inosine Monophosphate Dehydrogenase Inhibitor Mycophenolate Mofetil (Cellcept) in Advanced Multiple Myeloma Patients

JOURNAL ARTICLE published 15 December 2004 in Clinical Cancer Research

Authors: Naoko Takebe | Xiangfei Cheng | Suhlan Wu | Kenneth Bauer | Olga G. Goloubeva | Robert G. Fenton | Meyer Heyman | Aaron P. Rapoport | Ashraf Badros | John Shaughnessy | Douglas Ross | Barry Meisenberg | Guido Tricot

Anti-Folate Receptor Alpha–Directed Antibody Therapies Restrict the Growth of Triple-negative Breast Cancer

JOURNAL ARTICLE published 15 October 2018 in Clinical Cancer Research

Research funded by Breakthrough Breast Cancer (147) | Cancer Research UK (CRUK) (C30122/A11527) | Cancer Research UK (CRUK) (C30122/A15774) | Medical Research Council (MRC) (MR/L023091/1) | DH | National Institute for Health Research (NIHR) (IS-BRC-1215-20006) | Cancer Research UK (CRUK) (C10355/A15587) | Academy of Medical Sciences (Josephs)

Authors: Anthony Cheung | James Opzoomer | Kristina M. Ilieva | Patrycja Gazinska | Ricarda M. Hoffmann | Hasan Mirza | Rebecca Marlow | Erika Francesch-Domenech | Matthew Fittall | Diana Dominguez Rodriguez | Angela Clifford | Luned Badder | Nirmesh Patel | Silvia Mele | Giulia Pellizzari | Heather J. Bax | Silvia Crescioli | Gyula Petranyi | Daniel Larcombe-Young | Debra H. Josephs | Silvana Canevari | Mariangela Figini | Sarah Pinder | Frank O. Nestle | Cheryl Gillett | James F. Spicer | Anita Grigoriadis | Andrew N.J. Tutt | Sophia N. Karagiannis

Notch-1 Mutations Are Secondary Events in Some Patients with T-Cell Acute Lymphoblastic Leukemia

JOURNAL ARTICLE published 1 December 2007 in Clinical Cancer Research

Authors: Marc R. Mansour | Veronique Duke | Letizia Foroni | Bella Patel | Christopher G. Allen | Phil J. Ancliff | Rosemary E. Gale | David C. Linch

Phase Ib Study of Wnt Inhibitor Ipafricept with Gemcitabine and nab-paclitaxel in Patients with Previously Untreated Stage IV Pancreatic Cancer

JOURNAL ARTICLE published 15 October 2020 in Clinical Cancer Research

Research funded by HHS | NIH | National Cancer Institute (3P30 CA0062927)

Authors: Efrat Dotan | Dana B. Cardin | Heinz-Josef Lenz | Wells Messersmith | Bert O'Neil | Steven J. Cohen | Crystal S. Denlinger | Safi Shahda | Igor Astsaturov | Ann M. Kapoun | Rainer K. Brachmann | Shailaja Uttamsingh | Robert J. Stagg | Colin Weekes

A Model of Overall Survival Predicts Treatment Outcomes with Atezolizumab versus Chemotherapy in Non–Small Cell Lung Cancer Based on Early Tumor Kinetics

JOURNAL ARTICLE published 15 July 2018 in Clinical Cancer Research

Authors: Laurent Claret | Jin Y. Jin | Charles Ferté | Helen Winter | Sandhya Girish | Mark Stroh | Pei He | Marcus Ballinger | Alan Sandler | Amita Joshi | Achim Rittmeyer | David Gandara | Jean-Charles Soria | René Bruno

Role of the Erythropoietin Receptor in ETV6/RUNX1-Positive Acute Lymphoblastic Leukemia

JOURNAL ARTICLE published 15 November 2008 in Clinical Cancer Research

Authors: Andrea Inthal | Gerd Krapf | Dominik Beck | Ruth Joas | Max O. Kauer | Lukas Orel | Gerhard Fuka | Georg Mann | E. Renate Panzer-Grümayer

Initial Phase I Safety Study of Gedatolisib plus Cofetuzumab Pelidotin for Patients with Metastatic Triple-Negative Breast Cancer

JOURNAL ARTICLE published 2 August 2022 in Clinical Cancer Research

Research funded by NIH (NCI R21CA229951)

Authors: Milan Radovich | Jeffrey P. Solzak | Chao J. Wang | Bradley A. Hancock | Sunil Badve | Sandra K. Althouse | Steven M. Bray | Anna Maria V. Storniolo | Tarah J. Ballinger | Bryan P. Schneider | Kathy D. Miller

Expression and Gene Amplification of Actinin-4 in Invasive Ductal Carcinoma of the Pancreas

JOURNAL ARTICLE published 1 September 2008 in Clinical Cancer Research

Authors: Satoru Kikuchi | Kazufumi Honda | Hitoshi Tsuda | Nobuyoshi Hiraoka | Issei Imoto | Tomoo Kosuge | Tomoko Umaki | Kaoru Onozato | Miki Shitashige | Umio Yamaguchi | Masaya Ono | Akihiko Tsuchida | Tatsuya Aoki | Johji Inazawa | Setsuo Hirohashi | Tesshi Yamada

Cancer Therapy Associated Bone Loss: Implications for Hip Fractures in Mid-Life Women with Breast Cancer

JOURNAL ARTICLE published 1 February 2011 in Clinical Cancer Research

Authors: Beatrice J. Edwards | Dennis W. Raisch | Veena Shankaran | June M. McKoy | William Gradishar | Andrew D. Bunta | Athena T. Samaras | Simone N. Boyle | Charles L. Bennett | Dennis P. West | Theresa A. Guise

Gene Targeting Meets Cell-Based Therapy: Raising the Tail, or Merely a Whimper?

JOURNAL ARTICLE published 15 January 2017 in Clinical Cancer Research

Authors: Alexandria P. Cogdill | Peter A. Prieto | Alexandre Reuben | Jennifer A. Wargo

It Shouldn't Take Another 50 Years: Accelerating Momentum to End the Tobacco Epidemic

JOURNAL ARTICLE published 1 April 2014 in Clinical Cancer Research

Authors: Howard K. Koh

The Context of Blood Vessels and Response to VEGF-Targeted Therapy

JOURNAL ARTICLE published 15 December 2013 in Clinical Cancer Research

Authors: Brian I. Rini

Tamoxifen Resistance Trumped and Oral Selective Estrogen Receptor Degraders Arrive

JOURNAL ARTICLE published 1 August 2018 in Clinical Cancer Research

Research funded by University of Texas MD Anderson Cancer Center (CA 016672)

Authors: V. Craig Jordan

Abstract IA02: The Treehouse Childhood Cancer Initiative

JOURNAL ARTICLE published 15 June 2020 in Clinical Cancer Research

Authors: David Haussler

Molecular Pathways: New Signaling Considerations When Targeting Cytoskeletal Balance to Reduce Tumor Growth

JOURNAL ARTICLE published 1 December 2015 in Clinical Cancer Research

Authors: Kristi R. Chakrabarti | Lindsay Hessler | Lekhana Bhandary | Stuart S. Martin

Abstract A05: CD44, total protein, and p16 marker expression in oral rinses from oral and oropharyngeal cancer patients and controls

JOURNAL ARTICLE published 15 June 2020 in Clinical Cancer Research

Authors: Drew Smith | Elizabeth Franzmann | Michael Donovan